Role of RNA polymerase IV in the heterochromatic siRNA pathway

RNA聚合酶IV在异染色质siRNA途径中的作用

基本信息

  • 批准号:
    7220652
  • 负责人:
  • 金额:
    $ 25.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In organisms as diverse as humans, flies, nematodes, fission yeast and plants, small interfering RNAs (siRNAs) regulate essential processes that include viral defense, silencing of retrotransposons, inactivation of specific mRNAs and centromere maintenance. The mechanisms by which siRNAs target homologous RNAs for degradation in Dicer and RISC-mediated RNA interference (RNAi) pathways are fairly well understood. By contrast, the mechanisms by which siRNAs direct histone modifications and/or cytosine methylation events that silence and maintain heterochromatic loci are poorly understood. A newly discovered activity required in the heterochromatic siRNA pathway in Arabidopsis thaliana is Nuclear RNA polymerase IV (pol IV). The two largest subunits of pol IV are similar to the catalytic subunits of E. coli DNA-dependent RNA polymerase and to the corresponding subunits of eukaryotic nuclear RNA polymerases I, II, and III. Disruption of pol IV subunits causes heterochromatin to disperse coincident with losses in cytosine methylation and siRNA production at repetitive genes and retrotransposons. The simplest hypothesis is that pol IV generates precursor transcripts for Dicer-generated siRNAs that direct heterochromatin modifications to homologous sequences. Interestingly, pol IV appears to lack conventional RNA polymerase activity using double-stranded DNA as the template. Pol IV largest subunits also have non- canonical amino acids at the presumptive active site, suggesting the hypothesis that pol IV has a novel polymerase activity. The finding that pol IV-dependent siRNA production also requires RNA-dependent RNA polymerase 2 (RDR2) and cytosine methyltransferase activity (DRM or MET1) suggests that double- stranded RNA or methylated DNA could be specialized templates transcribed by pol IV. The aims of the proposed research are: 1) To determine the templates, products and subunits of pol IV; 2) To deduce the step at which pol IV acts in the heterochromatic siRNA pathway and 3) To test the hypothesis that two distinct forms of pol IV act non-redundantly in contributing to global heterochromatin organization. Chromatin modifications are increasingly linked to siRNA involvement and are implicated in numerous cancers as well as Rett, ICF, Prader-Willi, Beckwith-Wiedemann and Fragile X syndromes. Chromosome instability, also linked to siRNA involvement at centromeres, can lead to trisomies or embryo lethality. Moreover RNA interference shows promise as a gene-therapy tool with which to combat disease. Our studies, which make use of Arabidopsis unique genetic resources, may therefore shed light on mechanisms of siRNA production and chromatin modification that have relevance to human health.
描述(由申请人提供):在人类、苍蝇、线虫、裂殖酵母和植物等多种生物体中,小干扰RNA(siRNA)调节基本过程,包括病毒防御、逆转录转座子沉默、特定mRNA失活和着丝粒维持。siRNA靶向同源RNA以在Dicer和RISC介导的RNA干扰(RNAi)途径中降解的机制已经相当好地理解。相比之下,siRNA指导组蛋白修饰和/或胞嘧啶甲基化事件沉默和维持异染色质基因座的机制知之甚少。在拟南芥异染色质siRNA途径中所需的新发现的活性是核RNA聚合酶IV(pol IV)。pol IV的两个最大亚基与E. coli DNA依赖性RNA聚合酶和真核细胞核RNA聚合酶I、II和III的相应亚基。pol IV亚基的破坏导致异染色质分散,同时在重复基因和反转录转座子处胞嘧啶甲基化和siRNA产生的损失。最简单的假设是pol IV产生Dicer产生的siRNA的前体转录物,其指导异染色质修饰同源序列。有趣的是,pol IV似乎缺乏使用双链DNA作为模板的常规RNA聚合酶活性。Pol IV最大的亚基在推定的活性位点处也具有非规范氨基酸,这表明Pol IV具有新的聚合酶活性的假设。pol IV依赖性siRNA产生也需要RNA依赖性RNA聚合酶2(RDR 2)和胞嘧啶甲基转移酶活性(DRM或MET 1)的发现表明,双链RNA或甲基化DNA可以是由pol IV转录的特化模板。本研究的目的是:1)确定pol IV的模板、产物和亚基; 2)推断pol IV在异染色质siRNA途径中起作用的步骤; 3)检验pol IV的两种不同形式在促进全局异染色质组织中起非冗余作用的假设。染色质修饰越来越多地与siRNA参与有关,并且与许多癌症以及Rett、ICF、Prader-Willi、Beckwith-Wiedemann和脆性X综合征有关。染色体不稳定性,也与着丝粒处的siRNA参与有关,可导致三体或胚胎致死。此外,RNA干扰显示出作为对抗疾病的基因治疗工具的前景。因此,我们的研究,利用拟南芥独特的遗传资源,可能会揭示与人类健康相关的siRNA生产和染色质修饰的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CRAIG Stuart PIKAARD其他文献

CRAIG Stuart PIKAARD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CRAIG Stuart PIKAARD', 18)}}的其他基金

SPECIFICITY OF HISTONE ACETYLTRANSFERASE ENZYMES FROM ARABIDOPSIS THALIANA
拟南芥组蛋白乙酰转移酶的特异性
  • 批准号:
    7953917
  • 财政年份:
    2009
  • 资助金额:
    $ 25.58万
  • 项目类别:
SPECIFICITY OF HISTONE ACETYLTRANSFERASE ENZYMES FROM ARABIDOPSIS THALIANA
拟南芥组蛋白乙酰转移酶的特异性
  • 批准号:
    7721482
  • 财政年份:
    2008
  • 资助金额:
    $ 25.58万
  • 项目类别:
Roles of RNA Polymerases IV and V in siRNA-mediated gene silencing
RNA 聚合酶 IV 和 V 在 siRNA 介导的基因沉默中的作用
  • 批准号:
    8391724
  • 财政年份:
    2006
  • 资助金额:
    $ 25.58万
  • 项目类别:
Role of RNA polymerase IV in the heterochromatic siRNA pathway
RNA聚合酶IV在异染色质siRNA途径中的作用
  • 批准号:
    7599659
  • 财政年份:
    2006
  • 资助金额:
    $ 25.58万
  • 项目类别:
Roles of RNA Polymerases IV and V in siRNA-mediated gene silencing
RNA 聚合酶 IV 和 V 在 siRNA 介导的基因沉默中的作用
  • 批准号:
    8204558
  • 财政年份:
    2006
  • 资助金额:
    $ 25.58万
  • 项目类别:
Role of RNA polymerase IV in the heterochromatic siRNA pathway
RNA聚合酶IV在异染色质siRNA途径中的作用
  • 批准号:
    8037901
  • 财政年份:
    2006
  • 资助金额:
    $ 25.58万
  • 项目类别:
SPECIFICITY OF HISTONE ACETYLTRANSFERASE ENZYMES FROM ARABIDOPSIS THALIANA
拟南芥组蛋白乙酰转移酶的特异性
  • 批准号:
    7355309
  • 财政年份:
    2006
  • 资助金额:
    $ 25.58万
  • 项目类别:
Role of RNA polymerase IV in the heterochromatic siRNA pathway
RNA聚合酶IV在异染色质siRNA途径中的作用
  • 批准号:
    7088118
  • 财政年份:
    2006
  • 资助金额:
    $ 25.58万
  • 项目类别:
Roles of RNA Polymerases IV and V in siRNA-mediated gene silencing
RNA 聚合酶 IV 和 V 在 siRNA 介导的基因沉默中的作用
  • 批准号:
    8041251
  • 财政年份:
    2006
  • 资助金额:
    $ 25.58万
  • 项目类别:
Role of RNA polymerase IV in the heterochromatic siRNA pathway
RNA聚合酶IV在异染色质siRNA途径中的作用
  • 批准号:
    7410175
  • 财政年份:
    2006
  • 资助金额:
    $ 25.58万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.58万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了